Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- View the Talks
-
1. Mononuclear phagocytes - origins, fates and functions
- Prof. Steffen Jung
-
2. Transcription factors in macrophage differentiation
- Dr. Michael Sieweke
-
3. Fetal macrophages
- Prof. Paul Martin
-
4. The alveolar macrophage
- Dr. Ronald G. Crystal
-
5. Airway macrophages in health and disease
- Prof. Tracy Hussell
-
6. Intestinal macrophages - heterogeneity, origins and functions
- Prof. Allan Mowat
-
7. Osteoclasts: what do they do and how do they do it?
- Prof. Steven L. Teitelbaum
-
8. The biology of Fc receptors and complement receptors
- Prof. Steven Greenberg
-
10. Tumour-associated macrophages
- Prof. Michele De Palma
- Dr. Mario Squadrito
-
11. The recognition of pathogens by C-type lectins
- Prof. Gordon D. Brown
-
12. Macrophage phagocytosis
- Prof. Joel Swanson
-
13. Macrophage CD36 and atherosclerosis
- Dr. Maria Febbraio
-
14. Toll-Like receptor signaling and the innate immune response
- Dr. Kate Fitzgerald
-
15. Innate immune receptors as mediators of systemic inflammation and pathogenesis of malaria
- Prof. Ricardo Gazzinelli
-
17. Triggering receptors expressed on myeloid cells (TREM)
- Dr. Daniel W. McVicar
-
18. Influence of eicosanoid lipid mediators on macrophage innate immune functions
- Prof. Marc Peters-Golden
-
19. Macrophage paired receptor interactions
- Prof. Neil Barclay
-
20. Macrophage heterogeneity in atherosclerosis regression
- Prof. Edward Fisher
-
21. Gaucher disease: from lysosomal storage to immunopathology
- Prof. Johannes M.F.G. Aerts
-
22. Macrophage in asthma
- Prof. Douglas Robinson
-
23. The macrophage mannose receptor
- Dr. Luisa Martinez-Pomares
-
24. Myeloid-derived suppressor cells in cancer
- Prof. Dmitry Gabrilovich
-
25. EGF-TM7 receptors
- Dr. Jörg Hamann
- Dr. Hsi-Hsien Lin
-
26. Macrophages in helminth infection
- Prof. Judith Allen
- Archived Lectures *These may not cover the latest advances in the field
-
27. Immunosuppressive mechanisms in myeloid cells
- Prof. Dmitry Gabrilovich
Printable Handouts
Navigable Slide Index
- Introduction
- Talk outline
- DAP12 (TYROBP)
- TREM
- The TREM gene cluster
- Expression of the TREM in various leukocytes
- TREM-like transcript 6
- TREM-like transcript 4
- Cross presentation mediated by CD8+ DC
- TREM-like transcript 4 expression
- TREM-like transcript 4 function
- Antigens targeted to TREML4
- Human TREML4 remains an enigma
- TLT-2: a TREM-like receptor on WBCs
- TLT-2 potentiates neutrophil responses
- pDC-TREM (TREM5)
- TLT-1
- The receptor that started it all, TREM-1
- TREM-1
- Blocking TREM-1 rescues mice from endotoxemia
- TREM-1 synergizes with TLR ligands
- sTREM-1 as a marker of inflammatory disease
- TREM-1-derived 17mer
- TREM-1 blockade protects against colitis
- DEN-induced hepatocellular carcinoma (HCC)
- DEN-induced inflammation and TREM-1
- DEN-induced HCC and TREM-1 lacking mice
- TREM-1 ligand and platelet connection
- HMGB1 from dead & dying cells as TREM-1 ligand
- A hypothetical TREM-1 feedback regulatory loop
- TREM-1 summary
- TREM-2: a receptor that would make Janus proud
- TREM-2 partially activates immature DCs
- Osteoclastogenesis
- TREM-2 potentiates osteoclastogenesis
- TREM-2 potentiates osteoclast development
- Plexin-A1 regulation of osteoclastogenesis
- TLT-1 is involved in regulating osteoclastogenesis
- TREM-2 and autosomal recessive diseases
- TREM-2 as a negative regulator of inflammation
- Anti-inflammatory role of TREM-2
- TREM-2-mediates IL-4-driven macrophage fusion
- LAB negatively regulates TREM-2 signals
- Microglial TREM-2 enhances phagocytosis
- TREM-2 negatively regulates EAE
- TREM-2 ligands
- TREM-2 summary
- Concluding comments
Topics Covered
- TREM-Discovery
- Genomic organization and expression-TREM-Like Transcripts (TLT)
- 6-TREM-like Transcript-4 (TREML4) in antigen capture and processing
- TREM-like Transcript (TLT) 2 in neutrophil and T cell regulation
- TREM-like Transcript (TLT) 1 in platelet regulation
- TREM-1 in inflammatory disease and cancer
- TREM-2 in dendritic cell, preOsteoclast and macrophage regulation
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
McVicar, D.W. (2013, February 13). Triggering receptors expressed on myeloid cells (TREM) [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 30, 2024, from https://doi.org/10.69645/WQFP6130.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Daniel W. McVicar has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Immunology
Transcript
Please wait while the transcript is being prepared...
0:00
Hello. My name is Dan McVicar.
I'm a Senior Investigator
in the Cancer and
Inflammation Program
at the National
Cancer Institute.
I'm going to be
talking today about
the triggering
receptors expressed
on myeloid cells or the TREM.
I think you'll find this to be
a very interesting family of
receptors that's involved in
many facets of
immune regulation.
Because it is such a
broad and wide topic,
as I review it for you here,
I'm not going to be able
to cover everything.
I want to apologize
in advance to
those authors whose
work I'm not able to
specifically show you as I
introduce you to this
intriguing gene family.
0:35
I'm going to break the
presentation down into four parts.
First of all, talk briefly about
the discovery of this
receptor family.
Then we'll look at the
locus and the structure of
the proteins within
this receptor family.
Then I'll take you one by
one through descriptions
of most of the family
members of the family.
Lastly, I'll give you a
few final comments and
some outstanding
questions that we're
thinking about as we look
at this receptor family.
1:01
In order to appreciate the TREM
and where they
came from, really,
one has to know a
little bit about
this signaling
molecule called DAP12.
It's encoded by the gene TYROBP.
DAP12 was initially detected as
a co-precipitating
protein with activating
Ly49s and KIR.
These are the Class one
recognition receptors that
NK cells use to detect
self from non-self.
It has a molecular weight
of about 12 kiloDaltons,
as you would imagine
by the name.
It's a disulfide-linked dimer,
and it shifts up to
about 32 kiloDaltons
upon tyrosine phosphorylation.
It was cloned, but based on
its biochemical similarity to
the TCR zeta chain and
the Fc Epsilon Gamma chain
by the Lanier Lab in 1998.
The protein has a very
small extracellular domain,
and it has a negatively
charged transmembrane domain
due to an aspartic acid residue.
Each molecule has
a single tyrosine-based
immunoreceptor
activation motif or ITAM.
This is a motif that has
two tyrosines and
configuration for
phosphorylation that
are followed at
the plus three-position by
a leucine or other
hydrophobic residue.
As tyrosines are carefully
spaced so that they
fit perfectly into the
SH2 domains of the SIK,
namely tyrosine kinases,
which are the
tyrosine kinases that
mediate DAP12 signaling.
DAP 12 is expressed on
natural killer cells, of course,
but is extensively
expressed within
the myeloid
compartment and that's
where we're going to be
talking about it today.
I should also point
out that there is
a full presentation on
DAP12 by Eric Vivier
in this series,
and I recommend that you
take a look at that.